Keybanc Initiates Coverage On Absci with Overweight Rating, Announces Price Target of $3
Portfolio Pulse from Benzinga Newsdesk
Keybanc analyst Scott Schoenhaus has initiated coverage on Absci (NASDAQ:ABSI), a biotech company, with an Overweight rating and a price target of $3. This new coverage could influence investor sentiment and potentially impact Absci's stock price in the short term.
December 05, 2023 | 11:09 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Absci receives an Overweight rating and a $3 price target from Keybanc, which may positively affect its stock price as investors react to the new analyst coverage.
Analyst ratings, especially initiations of coverage, can have a significant impact on stock prices as they often lead to increased investor awareness and credibility. An Overweight rating suggests that the analyst believes the stock has a good chance of outperforming the market or its sector, which could lead to increased investor interest and a potential rise in the stock price. The announcement of a price target also provides a specific goal that can influence investor expectations and trading behavior.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100